[1]Chang J M, Lee H J, Goo J M, et al. False positive and false negative FDG-PET scans in various thoracic diseases[J]. Korean Journal of Radiology, 2006, 7(1): 57-69.
[2]Delbeke D, Coleman R E, Guiberteau M J, et al. Procedure guideline for tumor imaging with 18F-FDG PET/CT 1.0[J]. Journal of Nuclear Medicine, 2006, 47(5): 885-895.
[3]Qi Y, Liu X, Li J, et al. Fluorine-18 labeled amino acids for tumor PET/CT imaging[J]. Oncotarget, 2017, 8(36): 60581-60588.
[4]Tang G, Wang M, Tang X, et al. Pharmacokinetics and radiation dosimetry estimation of O-(2-[18F]fluoroethyl)-L-tyrosine as oncologic PET tracer[J]. Appl Radiat Isot, 2003, 58: 219-225.
[5]张锦明,黄伟,田嘉禾,等. 一种制备18F-FET的方法:中国,CN102336678A[P]. 2012-02-01.
[6]贾丽娜,张岚. 18F-DOPA制备研究进展[J]. 同位素,2017,30(1):71-77.Jia Lina, Zhang Lan. Research progress in the preparation of 18F-DOPA[J]. Journal of Isotopes, 2017, 30(1): 71-77(in Chinese).
[7]Kinoshita M, Arita H, Goto T, et al. A novel PET index, 18F-FDG-11C-methionine uptake decoupling score, reflects glioma cell infiltration[J]. Journal of Nuclear Medicine, 2012, 53(11): 1701-1708.
[8]Pauleit D, Stoffels G, Bachofner A, et al. Comparison of 18F-FET and 18F-FDG PET in brain tumors[J]. Nuclear Medicine and Biology, 2009, 36(7): 779-787.
[9]张岚,唐刚华,周伟,等. 6-18F-多巴的制备及其大鼠体内分布研究[J]. 中华核医学杂志,2002,22(5):57-58.Zhang lan, Tang Ganghua, Zhou Wei, et al. Preparation of 6-18F-DOPA and its biodistribution in rats[J]. Chinese Journal of Nuclear Mdeicine, 2002, 22(5): 57-58(in Chinese).
[10]Magistretti P J, Pellerin L. Cellular mechanisms of brain energy metabolism and their relevance to functional brain imaging[J]. Philos Trans R Soc Lond B Biol Sci, 1999, 354: 1155-1163.
[11]Wang H E, Wu S Y, Chang C W, et al. Evaluation of F-18-labeled amino acid derivatives and [18F]FDG as PET probes in a brain tumor-bearing animal model[J]. Nuclear Medicine and Biology, 2005, 32(4): 367-375.
[12]Lee T S, Ahn S H, Moon B S, et al. Comparison of 18F-FDG, 18F-FET and 18F-FLT for differentiation between tumor and inflammation in rats[J] Nuclear Medicine and Biology, 2009, 36: 681-686.
[13]Ishiwata K, Ido T, Takahashi T, et al. Feasibility study of fluorine-18 labeled dopa for melanoma imaging[J]. Nuclear Medicine and Biology, 1989, 16(4): 371-374.
[14]Wester H J, Herz M, Weber W, et al. Synthesis and radiopharmacology of O-(2-[18F]fluoroethyl)-L-tyrosine for tumor imaging[J]. Journal of Nuclear Medicine, 1999, 40(1): 205-212. |